Literature DB >> 28827346

Structures of phlebovirus glycoprotein Gn and identification of a neutralizing antibody epitope.

Yan Wu1,2, Yaohua Zhu3,4, Feng Gao5, Yongjun Jiao6, Babayemi O Oladejo1, Yan Chai1, Yuhai Bi1,2,7, Shan Lu8, Mengqiu Dong8, Chang Zhang1, Guangmei Huang1, Gary Wong1, Na Li9, Yanfang Zhang1, Yan Li1, Wen-Hai Feng3,4, Yi Shi1,2,7, Mifang Liang10, Rongguang Zhang9, Jianxun Qi1, George F Gao11,2,7,9,10,12.   

Abstract

Severe fever with thrombocytopenia syndrome virus (SFTSV) and Rift Valley fever virus (RVFV) are two arthropod-borne phleboviruses in the Bunyaviridae family, which cause severe illness in humans and animals. Glycoprotein N (Gn) is one of the envelope proteins on the virus surface and is a major antigenic component. Despite its importance for virus entry and fusion, the molecular features of the phleboviruse Gn were unknown. Here, we present the crystal structures of the Gn head domain from both SFTSV and RVFV, which display a similar compact triangular shape overall, while the three subdomains (domains I, II, and III) making up the Gn head display different arrangements. Ten cysteines in the Gn stem region are conserved among phleboviruses, four of which are responsible for Gn dimerization, as revealed in this study, and they are highly conserved for all members in Bunyaviridae Therefore, we propose an anchoring mode on the viral surface. The complex structure of the SFTSV Gn head and human neutralizing antibody MAb 4-5 reveals that helices α6 in subdomain III is the key component for neutralization. Importantly, the structure indicates that domain III is an ideal region recognized by specific neutralizing antibodies, while domain II is probably recognized by broadly neutralizing antibodies. Collectively, Gn is a desirable vaccine target, and our data provide a molecular basis for the rational design of vaccines against the diseases caused by phleboviruses and a model for bunyavirus Gn embedding on the viral surface.

Entities:  

Keywords:  RVFV; SFTSV; bunyavirus; glycoprotein; neutralizing antibody

Mesh:

Substances:

Year:  2017        PMID: 28827346      PMCID: PMC5594662          DOI: 10.1073/pnas.1705176114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  57 in total

1.  Risk assessment of the introduction of Rift Valley fever from the Horn of Africa to Yemen via legal trade of small ruminants.

Authors:  Shaif Abdo-Salem; Agnès Waret-Szkuta; François Roger; Marie-Marie Olive; Khalid Saeed; Véronique Chevalier
Journal:  Trop Anim Health Prod       Date:  2010-10-22       Impact factor: 1.559

Review 2.  Veterinary vaccines and their use in developing countries.

Authors:  J Lubroth; M M Rweyemamu; G Viljoen; A Diallo; B Dungu; W Amanfu
Journal:  Rev Sci Tech       Date:  2007-04       Impact factor: 1.181

3.  Crystal structure of glycoprotein C from Rift Valley fever virus.

Authors:  Moshe Dessau; Yorgo Modis
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-14       Impact factor: 11.205

4.  Acid-activated structural reorganization of the Rift Valley fever virus Gc fusion protein.

Authors:  S M de Boer; J Kortekaas; L Spel; P J M Rottier; R J M Moormann; B J Bosch
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

5.  Differential Use of the C-Type Lectins L-SIGN and DC-SIGN for Phlebovirus Endocytosis.

Authors:  Psylvia Léger; Marilou Tetard; Berthe Youness; Nicole Cordes; Ronan N Rouxel; Marie Flamand; Pierre-Yves Lozach
Journal:  Traffic       Date:  2016-04-21       Impact factor: 6.215

6.  Tissue tropism and target cells of NSs-deleted rift valley fever virus in live immunodeficient mice.

Authors:  Céline Gommet; Agnès Billecocq; Grégory Jouvion; Milena Hasan; Tânia Zaverucha do Valle; Laurent Guillemot; Charlène Blanchet; Nico van Rooijen; Xavier Montagutelli; Michèle Bouloy; Jean-Jacques Panthier
Journal:  PLoS Negl Trop Dis       Date:  2011-12-06

7.  Crystal Structure of Glycoprotein C from a Hantavirus in the Post-fusion Conformation.

Authors:  Shmuel Willensky; Hagit Bar-Rogovsky; Eduardo A Bignon; Nicole D Tischler; Yorgo Modis; Moshe Dessau
Journal:  PLoS Pathog       Date:  2016-10-26       Impact factor: 6.823

8.  The first imported case of Rift Valley fever in China reveals a genetic reassortment of different viral lineages.

Authors:  Jingyuan Liu; Yulan Sun; Weifeng Shi; Shuguang Tan; Yang Pan; Shujuan Cui; Qingchao Zhang; Xiangfeng Dou; Yanning Lv; Xinyu Li; Xitai Li; Lijuan Chen; Chuansong Quan; Qianli Wang; Yingze Zhao; Qiang Lv; Wenhao Hua; Hui Zeng; Zhihai Chen; Haofeng Xiong; Chengyu Jiang; Xinghuo Pang; Fujie Zhang; Mifang Liang; Guizhen Wu; George F Gao; William J Liu; Ang Li; Quanyi Wang
Journal:  Emerg Microbes Infect       Date:  2017-01-18       Impact factor: 7.163

9.  Synthesis, proteolytic processing and complex formation of N-terminally nested precursor proteins of the Rift Valley fever virus glycoproteins.

Authors:  Sonja R Gerrard; Stuart T Nichol
Journal:  Virology       Date:  2006-09-08       Impact factor: 3.616

10.  The first identification and retrospective study of Severe Fever with Thrombocytopenia Syndrome in Japan.

Authors:  Toru Takahashi; Ken Maeda; Tadaki Suzuki; Aki Ishido; Toru Shigeoka; Takayuki Tominaga; Toshiaki Kamei; Masahiro Honda; Daisuke Ninomiya; Takenori Sakai; Takanori Senba; Shozo Kaneyuki; Shota Sakaguchi; Akira Satoh; Takanori Hosokawa; Yojiro Kawabe; Shintaro Kurihara; Koichi Izumikawa; Shigeru Kohno; Taichi Azuma; Koichiro Suemori; Masaki Yasukawa; Tetsuya Mizutani; Tsutomu Omatsu; Yukie Katayama; Masaharu Miyahara; Masahito Ijuin; Kazuko Doi; Masaru Okuda; Kazunori Umeki; Tomoya Saito; Kazuko Fukushima; Kensuke Nakajima; Tomoki Yoshikawa; Hideki Tani; Shuetsu Fukushi; Aiko Fukuma; Momoko Ogata; Masayuki Shimojima; Noriko Nakajima; Noriyo Nagata; Harutaka Katano; Hitomi Fukumoto; Yuko Sato; Hideki Hasegawa; Takuya Yamagishi; Kazunori Oishi; Ichiro Kurane; Shigeru Morikawa; Masayuki Saijo
Journal:  J Infect Dis       Date:  2013-11-14       Impact factor: 5.226

View more
  43 in total

1.  A single-domain antibody inhibits SFTSV and mitigates virus-induced pathogenesis in vivo.

Authors:  Xilin Wu; Yanlei Li; Bilian Huang; Xiaohua Ma; Linjing Zhu; Nan Zheng; Shijie Xu; Waqas Nawaz; Changping Xu; Zhiwei Wu
Journal:  JCI Insight       Date:  2020-07-09

2.  Potent neutralization of Rift Valley fever virus by human monoclonal antibodies through fusion inhibition.

Authors:  Nathaniel S Chapman; Haiyan Zhao; Nurgun Kose; Jonna B Westover; Birte Kalveram; Robin Bombardi; Jessica Rodriguez; Rachel Sutton; Joseph Genualdi; A Desiree LaBeaud; Francis M Mutuku; Phillip R Pittman; Alexander N Freiberg; Brian B Gowen; Daved H Fremont; James E Crowe
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-06       Impact factor: 11.205

3.  Lrp1 is a host entry factor for Rift Valley fever virus.

Authors:  Safder S Ganaie; Madeline M Schwarz; Cynthia M McMillen; David A Price; Annie X Feng; Joseph R Albe; Wenjie Wang; Shane Miersch; Anthony Orvedahl; Aidan R Cole; Monica F Sentmanat; Nawneet Mishra; Devin A Boyles; Zachary T Koenig; Michael R Kujawa; Matthew A Demers; Ryan M Hoehl; Austin B Moyle; Nicole D Wagner; Sarah H Stubbs; Lia Cardarelli; Joan Teyra; Anita McElroy; Michael L Gross; Sean P J Whelan; John Doench; Xiaoxia Cui; Tom J Brett; Sachdev S Sidhu; Herbert W Virgin; Takeshi Egawa; Daisy W Leung; Gaya K Amarasinghe; Amy L Hartman
Journal:  Cell       Date:  2021-09-23       Impact factor: 66.850

4.  Antiviral activity and mechanism of the antifungal drug, anidulafungin, suggesting its potential to promote treatment of viral diseases.

Authors:  Shu Shen; Yaxian Zhang; Zhiyun Yin; Qiong Zhu; Jingyuan Zhang; Tiantian Wang; Yaohui Fang; Xiaoli Wu; Yuan Bai; Shiyu Dai; Xijia Liu; Jiayin Jin; Shuang Tang; Jia Liu; Manli Wang; Yu Guo; Fei Deng
Journal:  BMC Med       Date:  2022-10-21       Impact factor: 11.150

5.  Novel SFTSV Phylogeny Reveals New Reassortment Events and Migration Routes.

Authors:  Xiaoli Wu; Mingyue Li; Yanfang Zhang; Boyun Liang; Junming Shi; Yaohui Fang; Zhengyuan Su; Mengmeng Li; Wenjing Zhang; Ling Xu; Jun Wang; Qiaoli Wu; Shuang Tang; Hualin Wang; Tao Zhang; Cheng Peng; Xin Zheng; Fei Deng; Shu Shen
Journal:  Virol Sin       Date:  2020-09-22       Impact factor: 4.327

6.  Crystal structure of tomato spotted wilt virus GN reveals a dimer complex formation and evolutionary link to animal-infecting viruses.

Authors:  Yoav Bahat; Joel Alter; Moshe Dessau
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-05       Impact factor: 11.205

7.  The Postfusion Structure of the Heartland Virus Gc Glycoprotein Supports Taxonomic Separation of the Bunyaviral Families Phenuiviridae and Hantaviridae.

Authors:  Yaohua Zhu; Yan Wu; Yan Chai; Jianxun Qi; Ruchao Peng; Wen-Hai Feng; George Fu Gao
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

8.  Structure of severe fever with thrombocytopenia syndrome virus L protein elucidates the mechanisms of viral transcription initiation.

Authors:  Panpan Wang; Lu Liu; Aijun Liu; Liming Yan; Yong He; Shu Shen; Mingxu Hu; Yu Guo; Haiguang Liu; Chuang Liu; Yinying Lu; Peiyi Wang; Fei Deng; Zihe Rao; Zhiyong Lou
Journal:  Nat Microbiol       Date:  2020-04-27       Impact factor: 17.745

Review 9.  Rift Valley fever: biology and epidemiology.

Authors:  Daniel Wright; Jeroen Kortekaas; Thomas A Bowden; George M Warimwe
Journal:  J Gen Virol       Date:  2019-07-16       Impact factor: 5.141

10.  Shielding and activation of a viral membrane fusion protein.

Authors:  Steinar Halldorsson; Sai Li; Mengqiu Li; Karl Harlos; Thomas A Bowden; Juha T Huiskonen
Journal:  Nat Commun       Date:  2018-01-24       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.